Sicart Associates
MDT icon

Sicart Associates’s Medtronic MDT Stock Holding History

Sicart Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.8M Sell
71,814
-108
-0.2% -$9.5K 1.65% 21
2026
Q2 		$5.63M Sell
71,922
-665
-0.9% -$53.6K 1.38% 26
2026
Q1 		$6.29M Hold
72,587
– – 1.62% 24
2025
Q4 		$6.97M Sell
72,587
-140
-0.2% -$13.6K 1.85% 18
2025
Q3 		$6.93M Sell
72,727
-15
-0% -$1.38K 1.88% 19
2025
Q2 		$6.34M Sell
72,742
-2,548
-3% -$216K 2.22% 18
2025
Q1 		$6.82M Sell
75,290
-150
-0.2% -$13.4K 2.36% 15
2024
Q4 		$6.08M Sell
75,440
-3,020
-4% -$261K 2.17% 21
2024
Q3 		$7.12M Buy
78,460
+75
+0.1% +$6.31K 2.5% 15
2024
Q2 		$6.22M Sell
78,385
-1,387
-2% -$114K 2.39% 18
2024
Q1 		$7.01M Sell
79,772
-1,489
-2% -$127K 2.57% 17
2023
Q4 		$6.75M Sell
81,261
-2,777
-3% -$212K 2.58% 15
2023
Q3 		$6.64M Buy
84,038
+348
+0.4% +$29.1K 2.61% 14
2023
Q2 		$7.38M Buy
83,690
+69,610
+494% +$5.99M 2.87% 13
2023
Q1 		$1.14M Sell
14,080
-2,611
-16% -$213K 0.45% 43
2022
Q4 		$1.31M Sell
16,691
-3,615
-18% -$293K 0.46% 44
2022
Q3 		$1.65M Sell
20,306
-3,145
-13% -$283K 0.59% 38
2022
Q2 		$2.12M Buy
23,451
+953
+4% +$96.6K 0.66% 38
2022
Q1 		$2.51M Sell
22,498
-2,110
-9% -$223K 0.65% 38
2021
Q4 		$2.59M Sell
24,608
-919
-4% -$106K 0.67% 36
2021
Q3 		$3.22M Sell
25,527
-1,325
-5% -$171K 0.88% 33
2021
Q2 		$3.35M Sell
26,852
-350
-1% -$43.9K 0.8% 33
2021
Q1 		$3.23M Sell
27,202
-1,176
-4% -$138K 0.85% 31
2020
Q4 		$3.34M Buy
28,378
+4,730
+20% +$521K 0.83% 31
2020
Q3 		$2.47M Sell
23,648
-210
-0.9% -$21.1K 0.74% 34
2020
Q2 		$2.2M Buy
+23,858
New +$2.29M 0.7% 37

Other funds holding MDT

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Sicart Associates's MDT Position: Q3 2026 in Review

Sicart Associates reduced its Medtronic (MDT) stake by 0.15% in Q3 2026, selling an estimated $9.5K and leaving 71,814 shares worth $6.8M. The position accounts for 1.65% of the portfolio, ranked #21.

Sicart Associates first reported a position in MDT in Q2 2020 and has held it in 26 quarters since. The position peaked at $7.38M in Q2 2023. 917 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Sicart Associates held 71,814 shares of Medtronic worth $6.8M as of Q3 2026.
  • Sicart Associates sold 108 Medtronic shares in Q3 2026, an estimated $9.5K.
  • Medtronic made up 1.65% of Sicart Associates's portfolio in Q3 2026, its #21 holding.
  • Sicart Associates first reported a position in Medtronic in Q2 2020 and has held it in 26 quarters since.
  • Sicart Associates's Medtronic position peaked at $7.38M in Q2 2023.
  • 917 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Sicart Associates's 13F filing for Q3 2026, filed 29 Oct 2026.